President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases. 

The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.

"We're going to be able to make that drug available almost immediately," Trump said. 

The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.

He also tempered the president's optimism about the still-untested solution. 

"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."

New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.  

"The therapies are something we could move on much faster potentially," Trump said. 

He claimed the administration "slashed red tape" to develop new vaccines and therapies.

The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks

"If we find that we need something, then we will do that," he said.  

Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak. 

The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.

"We continue our relentless effort to defeat the Chinese virus," Trump said.

Share:
More In Politics
McCarthy Struggles for Debt Bill Votes, Makes Late Changes
House Republicans made post-midnight changes to their sweeping debt ceiling package to win over holdouts, as Speaker Kevin McCarthy pushed ahead Wednesday with plans to launch debate and round up support from his slim majority for a vote this week.
Biden Thanks 'Tennessee Three' for 'Standing Up' for Gun Control
Three Tennessee lawmakers who became Democratic heroes for facing expulsion after participating in gun control protests visited the White House on Monday, describing themselves as “representatives of a movement" that is demanding greater restrictions on firearms to save lives.
Speaker McCarthy Faces Big Test as Debt Bill Heads for Vote
Speaker Kevin McCarthy is hurtling toward one of the most consequential weeks of the new House Republican majority as he labors to pass a partisan package that would raise the nation's debt limit by $1.5 trillion in exchange for steep cuts that some in his own party oppose.
Biden Announces 2024 Reelection Bid: 'Let’s Finish This Job'
President Joe Biden on Tuesday formally announced that he is running for reelection in 2024, asking voters to give him more time to “finish this job” he began when he was sworn into office and to set aside their concerns about extending the run of America’s oldest president for another four years.
Load More